Prescription Pattern of Corticosteroids in Zanjan, Iran Corticosteroid Prescription in Iran
Iranian Journal of Pharmaceutical Sciences,
Vol. 12 No. 4 (2016),
1 October 2016
,
Page 63-68
https://doi.org/10.22037/ijps.v12.40714
Abstract
The aim of the present study was to provide a clear picture of the prescribing pattern of corticosteroids in Zanjan, Iran. A retrospective and cross-sectional study was conducted to describe the pattern of corticosteroids prescription at Beheshti pharmacy (Zanjan, Iran) over a period of six months between March 21 and September 22, 2013. Descriptive analyses were stratified by gender, age, type of prescribed corticosteroid and rout of administration. Separate analyses were performed to determine the most common indications leading to the prescription of injection dexamethasone. Corticosteroids were prescribed mostly (74.56%) as injection. The overall corticosteroid prescribing rate was 25.73%; 55.86%, and 44.14% in females and males, respectively. Corticosteroids were prescribed frequently for adults in both males and females. In young and middle-aged women, corticosteroids were prescribed substantially higher than in men of the same age. Dexamethasone as the most prescribed corticosteroid in both male and females was mostly prescribed for respiratory bacterial infections. The current study grows the knowledge about the use of corticosteroids in Iran and suggests more attempts to reduce corticosteroids prescription. Educational interventions to promote hygiene in the society could improve rational use of corticosteroids.
- Age
- Ambulatory care
- Dexamethasone
- Gender
- Prescribing pattern
- Respiratory infection
How to Cite
References
[2]. Salamzadeh J. Asthma: Achievements and Questions in Front. IJPS (2005)1(2): 63-76
[3]. Blumstein H, Gorevic PD. Rheumatologic illnesses: treatment strategies for older adults. Geriatrics (2005) 60(6): 28-35.
[4]. Vyvey M. Steroids as pain relief adjuvants. Can Fam Physician (2010)56(12): 1295-1297.
[5]. Grunberg SM. Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis. Ann Oncol (2007)18 (2): 233-240.
[6]. Soleymani F, Valadkhani M, Dinarvand R. Challenges and Achievements of Promoting Rational Use of Drugs in Iran. Iranian J Publ Health (2009)38: 166-168
[7]. Karimi A, Haerizadeh M, Soleymani F, Haerizadeh M, Taheri F. Evaluation of medicine prescription pattern using World Health Organization prescribing indicators in Iran: A cross-sectional study. Res Pharm Pract (2014) 3(2): 39–45.
[8]. Yousefi N, Majdzadeh R, Valadkhani M, Nedjat S, Mohammadi H. Reasons for Physicians’ Tendency to Irrational Prescription of Corticosteroids. Iran Red Crescent Med J (2012)14(11): 713-718.
[9]. Ismaeilzadeh A, Nikfar S, Rahimi W. Physicians' Attitude Toward Injectable Medicines. J Pharm Toxicol (2006)1(1): 33-39.
[10]. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment 2013. Oslo, 2012.
[11]. Galdas PM, Cheater F, Marshall P. Men and health help-seeking behaviour: literature review. J Adv Nurs (2005) 49(6): 616-623.
[12]. Bisno AL. Acute pharyngitis. Acute pharyngitis.N Engl JMed (2001) 344(3): 205-211.
[13]. Vincent MT, Celestin N, Hussain AN. Pharyngitis. Am Fam Physician (2004) 69(6): 1465-1670.
[14]. Woodwell DA. National ambulatory medical care survey: 1998 summary. Adv Data (1997) 295: 1-25.
[15]. Zalmanovici A, Yaphe J. Steroids for acute sinusitis. Cochrane Database Syst Rev (2007)18(2): CD005149.
[16]. Hayward G, Thompson M, Heneghan C, Perera R, Del Mar C, Glasziou P. Corticosteroids for pain relief in sore throat: systematic review and meta-analysis. BMJ (2009) 6: 339: b2976.
[17]. Mygind N, Nielsen LP, Hoffmann HJ, Shukla A, Blumberga G, Dahl R, Jacobi H. Mode of action of intranasal corticosteroids. J Allergy Clin Immunol (2001)108(1suppl): S16-25.
[18]. Marvez-Valls EG, Stuckey A, Ernst AA. A randomized clinical trial of oral versus intramuscular delivery of steroids in acute exudative pharyngitis. Acad Emerg Med (2002) 9 (1): 9-14.
[19]. World health Organization. How to investigate drug use in health facilities: selected drug use indicators.Geneva (1993). http://apps.who.int/medicinedocs/en/d/Js2289e (Accessed April 4, 2016)
- Abstract Viewed: 410 times
- IJPS_Volume 12_Issue 4_Pages 63-68 Downloaded: 265 times